Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. - Wikidata - awgldk - TriplyDB

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

http://www.wikidata.org/entity/Q34677531

about

Focal nodular hyperplasia that mimicked a liver metastasis from a soft tissue sarcoma: a case report Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.Laparoscopic management of gastric gastrointestinal stromal tumors: A retrospective 10-year single-center experience.Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin The cut-off value of tumor size and appropriate timing of follow-up for management of minimal EUS-suspected gastric gastrointestinal stromal tumors.Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study.Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.Mucocele complicating stapled hemorrhoidopexy.Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.Olaratumab for advanced soft tissue sarcoma.Comparison of short- and long-term outcomes of laparoscopic vs open resection for gastric gastrointestinal stromal tumors.Surveillance for lung metastasis from giant cell tumor of bone.Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.Recent advances in managing gastrointestinal stromal tumor.An unexpected cause of gastric submucosal lesion Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study.Laparoscopic Versus Open Resection for Gastric Gastrointestinal Stromal Tumors (GISTs): A Size-Location-Matched Case-Control Study.Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.Major vascular resections in retroperitoneal sarcoma.Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease.Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study.Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.Editorial Comment from Dr Taguchi to Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan.[Treatment of retroperitoneal sarcoma in Germany : Results of a survey of the German Society of General and Visceral Surgery, the German Interdisciplinary Sarcoma Study Group and the advocacy group Das Lebenshaus].Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.Management of hemorrhage in gastrointestinal stromal tumors: a review.Developments in the management of advanced soft-tissue sarcoma - olaratumab in context.Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma.Sporadic Abdominal Wall Desmoid type Fibromatosis: treatment paradigm after thirty two years.Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas.Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy Improved survival using specialized multidisciplinary board in sarcoma patients

P2860

Q33617391-A4D16BE7-B32E-49F6-AB56-1A1557F6597A Q33689077-ACAB0570-F905-48B0-A82B-06BB676539A4 Q33719991-F4A4F406-0FAD-45D3-80E1-820F0B906732 Q33890846-77709951-FED6-4A00-BC9E-D68CE44219D9 Q36246657-053D2B00-0C7C-45D7-ACEF-EC0484E8A2C0 Q36341242-57873BEB-D561-49D3-831C-CDB744FDCC5A Q37670683-FE55BB9C-2C66-42A2-BA1F-D718E2DCC8B7 Q37682766-640652F8-756C-4A35-94D8-2EC2C482A81B Q37705793-BA930A73-4D6D-46D7-85A3-7A2128700CF7 Q38377472-FE9049F3-4E3D-4778-86EE-438FAC7C162C Q38663472-C77B72BE-62A2-4288-8715-1B11C1D53820 Q38709020-3187569C-B4A4-4DBA-B5A7-5FD494435E02 Q39454037-9E2FAF90-F60C-418A-8A7B-07B7863E3C78 Q41691560-0B64C20F-0603-4862-A7A6-F78BEA4F7FF3 Q41725812-F9C2AA6F-E4A9-49B9-9375-959E961E644A Q42112897-293A2B8E-8A75-428D-B65F-32C5F32FA30B Q46335861-067DE595-B271-42DE-B873-AE0056A34B8E Q47103057-E362A54F-24CF-425D-80A6-57179CF0B3A9 Q47225333-B1237DB7-982B-47DC-B99A-8D7BF5AE6B6C Q47761940-29F347BC-C40B-4355-931C-515215709224 Q48197570-A38FEAEA-57C5-4892-973C-27C8F2A18264 Q48246780-D806555E-B3D5-46B7-9B66-D3149A81178A Q48563213-4788DC6B-3563-40D9-819D-B8A7B29751A6 Q49691413-6696D0EA-E429-4A05-BF53-652249D04982 Q49966909-DD7C3718-CBE0-408C-914A-E374387321FB Q49975231-2EAC755A-A3E9-4281-B2F4-CC7A29ADBD1E Q50110554-F41BEDBC-9D67-4027-AED8-4DAC8ABBB0D1 Q50142799-95584D02-8B95-4F08-B433-C5EE2916DCE4 Q50969606-6DC6A519-2E89-4C0A-8159-9929B056F208 Q52562706-555C2F9A-3EEB-404D-996B-F44658458B95 Q52678077-AC8CCF41-BA72-48BA-88D2-888418D108FB Q55216228-F2FF90EF-4715-4F35-A679-72BDA6800FE3 Q55236680-F7ED80B7-6F19-41CC-B221-8E06815D1D90 Q55260657-40418637-EF30-405B-B384-8C04EE2CA0F1 Q55333386-1C60D125-DC45-41D3-BE22-6E35454E1125 Q55686663-81CC2966-EC43-4171-8D35-9567E342D4D5 Q57057521-FC981729-9C13-4111-AA8A-173518AFB63A Q57570446-728C20CA-8E1F-433B-9950-D8AB70B29A3F

P2860

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

http://www.wikidata.org/entity/Q34677531

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@ast

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@en

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@nl

type

label

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@ast

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@en

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@nl

prefLabel

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@ast

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@en

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@nl

P1433

Q34677531-4A83B45A-F5E5-459B-99C9-FAAD4BDF62A2

P1476

Q34677531-1523C9B9-3EF2-457D-8009-9140DD88E2DC

P2093

Q34677531-033FAE9F-4B34-4DFC-AF6F-40FEFEDC75C7

Q34677531-04F8B2CE-2346-4354-9553-E73B945E7520

Q34677531-15178597-42D3-4D7F-AF4E-98DFF8A2DA5C

Q34677531-2489393A-534E-45B3-9D69-81F93D2DC751

Q34677531-26851255-1941-4237-9364-825B47653E7A

Q34677531-2989B3BC-CE0B-48D8-8821-89D116C2698D

Q34677531-2F5E7504-AA09-4072-8874-530A11243EFA

Q34677531-30CA166E-6358-42EA-B6CD-44AB853B2D22

Q34677531-36A4830C-EFE6-4675-BEF3-9659694DF194

Q34677531-55E3418C-762C-48E7-9626-5F336EA2BB16

P304

Q34677531-DA249CCF-8150-4B65-B1E5-FB1F05FFB070

P31

Q34677531-5D924FD0-AFE0-4760-80F2-9B1B99C6A606

P356

Q34677531-ED93EA3D-247B-4AB9-9D19-450A455E27D2

P433

Q34677531-A1810D93-AB80-4C78-AEAB-22A3FA6FE746

P478

Q34677531-5E076CAF-E2B3-4AF7-9FCB-4BD49F6C0AA5

P50

Q34677531-73840D74-07C3-4491-B5FB-6C9B9F8D90B3

P577

Q34677531-25474568-0D74-4EE5-A5CD-6273AE9B8974

P698

Q34677531-5B272F44-B0D8-45CA-876B-FEA9F88B8777

P356

JNCCN.2016.0078

P1433

Journal of the National Comprehensive Cancer Network

P1476

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

@en

P2093

Alberto S Pappo

http://www.w3.org/2001/XMLSchema#string

Christian Meyer

http://www.w3.org/2001/XMLSchema#string

Ernest U Conrad

http://www.w3.org/2001/XMLSchema#string

Henry Koon

http://www.w3.org/2001/XMLSchema#string

Herbert S Schwartz

http://www.w3.org/2001/XMLSchema#string

I Benjamin Paz

http://www.w3.org/2001/XMLSchema#string

Ivy A Petersen

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Wayne

http://www.w3.org/2001/XMLSchema#string

Jillian Scavone

http://www.w3.org/2001/XMLSchema#string

Joel Mayerson

http://www.w3.org/2001/XMLSchema#string

P304

758-786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2016.0078

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Margaret von Mehren

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27283169

http://www.w3.org/2001/XMLSchema#string